With so many central banks meeting this week, Saxo's Kay Van-Petersen discusses the currency...

Biotechnology stocks have fallen significantly since their July peak. But because of the noise...

The massive rally in the biotechnology sector is not over according to Serge Berger, also known...

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

Serge Berger, who is also known as The Steady Trader, believes the NASDAQ Biotechnology ETF...

It's the largest US stock exchange in terms of volume and market share and the Nasdaq is...

Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...

It’s been revealed that talks between US agricultural giant Monsanto and its rival Syngenta have...

Agricultural giant Monsanto will maintain its competitive advantage according to research company...

Because markets have been choppy over the past few months, Swiss-based Trader Serge Berger, also...

Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...

The US healthcare sector is booming due to a combination of Obamacare and the approval of new...